SLI
2.001,58
PKT
-19,28
PKT
-0,95
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
14.07.21 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
14.07.21 | Givaudan Buy | UBS AG | |
14.07.21 | Swiss Re Overweight | JP Morgan Chase & Co. | |
14.07.21 | Roche Buy | Jefferies & Company Inc. | |
13.07.21 | UBS Buy | Deutsche Bank AG | |
13.07.21 | Roche Buy | Deutsche Bank AG | |
13.07.21 | ams-OSRAM Neutral | UBS AG | |
13.07.21 | UBS Buy | UBS AG | |
13.07.21 | ams-OSRAM Neutral | Oddo BHF | |
12.07.21 | Givaudan Equal-weight | Morgan Stanley | |
12.07.21 | UBS Equal-weight | Morgan Stanley | |
12.07.21 | Novartis Buy | Jefferies & Company Inc. | |
12.07.21 | Roche Hold | Jefferies & Company Inc. | |
12.07.21 | ams-OSRAM Underweight | Barclays Capital | |
09.07.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
09.07.21 | UBS Sector Perform | RBC Capital Markets | |
09.07.21 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.07.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
08.07.21 | UBS Neutral | JP Morgan Chase & Co. | |
08.07.21 | Holcim Hold | Jefferies & Company Inc. | |
06.07.21 | UBS Neutral | Goldman Sachs Group Inc. | |
06.07.21 | UBS Underweight | Barclays Capital | |
07.07.21 | UBS Overweight | JP Morgan Chase & Co. | |
07.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
07.07.21 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
07.07.21 | Nestlé Outperform | Bernstein Research | |
07.07.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
05.07.21 | Roche Neutral | JP Morgan Chase & Co. | |
02.07.21 | UBS Sector Perform | RBC Capital Markets | |
02.07.21 | ABB (Asea Brown Boveri) Buy | Kepler Cheuvreux | |
02.07.21 | Givaudan Neutral | Goldman Sachs Group Inc. | |
01.07.21 | ams-OSRAM Equal-weight | Morgan Stanley | |
01.07.21 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
30.06.21 | Roche Outperform | Bernstein Research | |
30.06.21 | Nestlé overweight | JP Morgan Chase & Co. | |
30.06.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
29.06.21 | Roche Neutral | JP Morgan Chase & Co. | |
29.06.21 | Nestlé overweight | Morgan Stanley | |
29.06.21 | Givaudan Underperform | Jefferies & Company Inc. | |
29.06.21 | Nestlé buy | Goldman Sachs Group Inc. |